Physician profile
Deborah E Mann
NPI 1063478485
$2,128.05
in general payments reported to CMS, 2019-2025
22 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $144 · 2021: $274 · 2022: $240 · 2023: $537 · 2024: $417 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $466.67 | 2020-2025 | Hydrus Microstent, Rocklatan, Tryptyr |
| Johnson & Johnson Vision Care, INC. | $413.16 | 2019-2025 | Acuvue |
| Novartis Pharmaceuticals Corporation | $202.05 | 2020-2023 | |
| Bausch & Lomb Americas INC. | $136.62 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Glaukos Corporation | $125.68 | 2019-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Sun Pharmaceutical Industries INC. | $123.20 | 2019-2025 | Cequa |
| Thea Pharma INC. | $115.39 | 2022-2024 | Iyuzeh |
| Dompe US, INC. | $108.41 | 2024-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $95.09 | 2019-2021 | |
| Oyster Point Pharma, INC. | $82.69 | 2023-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Genentech USA, INC. | $46.79 | 2023-2024 | Vabysmo |
| Shire North American Group INC | $44.41 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $22.75 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $22.41 | 2021 | |
| Harrow Eye, LLC | $20.99 | 2025 | Iheezo |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $20.29 | 2022 | |
| Abbvie INC. | $20.09 | 2024 | |
| Lkc Technologies, INC. | $14.71 | 2024 | |
| Eyepoint US, INC. | $12.05 | 2019 | |
| Horizon Therapeutics Plc | $11.84 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $11.66 | 2019 | |
| Allergan, INC. | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.